new indications for glp 1 drugs GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 Analogue Drugs: Top Brands,
Description
The role of tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: The SURPASS clinical trials
Although AOM liraglutide (Saxenda) has been approved for treatment of obesity in adolescents since late 2020 ( 5 ), the approval of AOM semaglutide (Wegovy) in December 2022 for treatment of obesity for adolescents prompted new excitement ( 6 )
[DOI] [PMC free article] [PubMed] [Google Scholar] 228
Current understanding of dysbiosis in disease in human and animal models
In the pancreas, glucagon has physiologically relevant cross-reactivity with GLP-1R, with an EC 50 of 36.4 0.22 nM, but there is no affinity of GLP-1 to the glucagon receptor [365]
Anesthesia providers assess this risk and may implement protective strategies based on individual patient factors
